documents: FDA-2007-D-0369-0275

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-0275 FDA FDA-2007-D-0369 Draft Guidance for Industry on Bioequivalence Recommendations for Fluticasone Propionate; Salmeterol Xinafoate; Reopening of the Comment Period Notice Notice of Availability 2013-11-27T05:00:00Z 2013 11 2013-11-27T05:00:00Z 2013-12-12T04:59:59Z 2013-12-08T18:23:54Z 2013-28394 0 0 090000648149c332

Links from other tables